Clinical progress note: Secondary fracture prevention.
Where this comes from
- Record sourced from PubMed, PMID 40223698.
- Also identified by DOI 10.1002/jhm.70062.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Osteoporosis is underdiagnosed and undertreated after fragility fractures. Hospitalists should be able to risk stratify osteoporosis severity to guide treatment decisions. Bisphosphonates remain the cornerstone of treatment. However, patients with the highest fracture risk may benefit from anabolic therapy before bisphosphonate use. Behavioral and environmental fall prevention measures also play a key role to prevent future fractures. Hospitalists are well-positioned to help address the gap in osteoporosis care-especially for patients who have already fractured and are at highest risk.
Medical subject headings
- Osteoporosis
- Secondary Prevention
- Osteoporotic Fractures